The ABC-Type Efflux Pump MacAB Protects Salmonella enterica serovar Typhimurium from Oxidative Stress

ABSTRACT Multidrug efflux pumps are integral membrane proteins known to actively excrete antibiotics. The macrolide-specific pump MacAB, the only ABC-type drug efflux pump in Salmonella, has previously been linked to virulence in mice. The molecular mechanism of this link between macAB and infection is unclear. We demonstrate that macAB plays a role in the detoxification of reactive oxygen species (ROS), compounds that salmonellae are exposed to at various stages of infection. macAB is induced upon exposure to H2O2 and is critical for survival of Salmonella enterica serovar Typhimurium in the presence of peroxide. Furthermore, we determined that macAB is required for intracellular replication inside J774.A1 murine macrophages but is not required for survival in ROS-deficient J774.D9 macrophages. macAB mutants also had reduced survival in the intestine in the mouse colitis model, a model characterized by a strong neutrophilic intestinal infiltrate where bacteria may experience the cytotoxic actions of ROS. Using an Amplex red-coupled assay, macAB mutants appear to be unable to induce protection against exogenous H2O2 in vitro, in contrast to the isogenic wild type. In mixed cultures, the presence of the wild-type organism, or media preconditioned by the growth of the wild-type organism, was sufficient to rescue the macAB mutant from peroxide-mediated killing. Our data indicate that the MacAB drug efflux pump has functions beyond resistance to antibiotics and plays a role in the protection of Salmonella against oxidative stress. Intriguingly, our data also suggest the presence of a soluble anti-H2O2 compound secreted by Salmonella cells through a MacAB-dependent mechanism. IMPORTANCE The ABC-type multidrug efflux pump MacAB is known to be required for Salmonella enterica serovar Typhimurium virulence after oral infection in mice, yet the function of this pump during infection is unknown. We show that this pump is necessary for colonization of niches in infected mice where salmonellae encounter oxidative stress during infection. MacAB is required for growth in cultured macrophages that produce reactive oxygen species (ROS) but is not needed in macrophages that do not generate ROS. In addition, we show that MacAB is required to resist peroxide-mediated killing in vitro and for the inactivation of peroxide in the media. Finally, wild-type organisms, or supernatant from wild-type organisms grown in the presence of peroxide, rescue the growth defect of macAB mutants in H2O2. MacAB appears to participate in the excretion of a compound that induces protection against ROS-mediated killing, revealing a new role for this multidrug efflux pump. The ABC-type multidrug efflux pump MacAB is known to be required for Salmonella enterica serovar Typhimurium virulence after oral infection in mice, yet the function of this pump during infection is unknown. We show that this pump is necessary for colonization of niches in infected mice where salmonellae encounter oxidative stress during infection. MacAB is required for growth in cultured macrophages that produce reactive oxygen species (ROS) but is not needed in macrophages that do not generate ROS. In addition, we show that MacAB is required to resist peroxide-mediated killing in vitro and for the inactivation of peroxide in the media. Finally, wild-type organisms, or supernatant from wild-type organisms grown in the presence of peroxide, rescue the growth defect of macAB mutants in H2O2. MacAB appears to participate in the excretion of a compound that induces protection against ROS-mediated killing, revealing a new role for this multidrug efflux pump.

[1]  J. Martínez,et al.  RND multidrug efflux pumps: what are they good for? , 2013, Front. Microbio..

[2]  I. Lasa,et al.  Effect of Transcriptional Activators SoxS, RobA, and RamA on Expression of Multidrug Efflux Pump AcrAB-TolC in Enterobacter cloacae , 2012, Antimicrobial Agents and Chemotherapy.

[3]  A. Nusrat,et al.  Enteric Commensal Bacteria Induce Extracellular Signal-regulated Kinase Pathway Signaling via Formyl Peptide Receptor-dependent Redox Modulation of Dual Specific Phosphatase 3* , 2011, The Journal of Biological Chemistry.

[4]  F. Fang Antimicrobial Actions of Reactive Oxygen Species , 2011, mBio.

[5]  A. Yamaguchi,et al.  Regulation of the AcrAB multidrug efflux pump in Salmonella enterica serovar Typhimurium in response to indole and paraquat. , 2011, Microbiology.

[6]  J. Imlay,et al.  The SoxRS response of Escherichia coli is directly activated by redox‐cycling drugs rather than by superoxide , 2011, Molecular microbiology.

[7]  B. McCollister,et al.  Nitric Oxide Protects Bacteria from Aminoglycosides by Blocking the Energy-Dependent Phases of Drug Uptake , 2011, Antimicrobial Agents and Chemotherapy.

[8]  K. Poole,et al.  Oxidative Stress Induction of the MexXY Multidrug Efflux Genes and Promotion of Aminoglycoside Resistance Development in Pseudomonas aeruginosa , 2010, Antimicrobial Agents and Chemotherapy.

[9]  G. Klein,et al.  Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. , 2009, The Journal of antimicrobial chemotherapy.

[10]  D. Landman,et al.  Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. , 2009, The Journal of antimicrobial chemotherapy.

[11]  S. Porwollik,et al.  Analysis of Pools of Targeted Salmonella Deletion Mutants Identifies Novel Genes Affecting Fitness during Competitive Infection in Mice , 2009, PLoS pathogens.

[12]  M. Morikawa,et al.  Flexible exportation mechanisms of arthrofactin in Pseudomonas sp. MIS38 , 2009, Journal of applied microbiology.

[13]  A. Yamaguchi,et al.  Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. , 2009, Biochimica et biophysica acta.

[14]  T. Tsuchiya,et al.  Multidrug efflux transporters in the MATE family. , 2009, Biochimica et biophysica acta.

[15]  S. Yaron,et al.  Regulation of marA, soxS, rob, acrAB and micF in Salmonella enterica serovar Typhimurium , 2008, Microbiology and immunology.

[16]  H. Andrews-Polymenis,et al.  ‘Form variation’ of the O12 antigen is critical for persistence of Salmonella Typhimurium in the murine intestine , 2008, Molecular microbiology.

[17]  E. Takahashi,et al.  MacAB Is Involved in the Secretion of Escherichia coli Heat-Stable Enterotoxin II , 2008, Journal of bacteriology.

[18]  A. Dinner,et al.  The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism , 2008, Proceedings of the National Academy of Sciences.

[19]  A. Yamaguchi,et al.  AcrAB Multidrug Efflux Pump Regulation in Salmonella enterica serovar Typhimurium by RamA in Response to Environmental Signals , 2008, Journal of Biological Chemistry.

[20]  W. Stiekema,et al.  Genetic and functional characterization of the gene cluster directing the biosynthesis of putisolvin I and II in Pseudomonas putida strain PCL1445. , 2008, Microbiology.

[21]  J. Imlay Cellular defenses against superoxide and hydrogen peroxide. , 2008, Annual review of biochemistry.

[22]  R. Pridmore,et al.  Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. , 2008, FEMS microbiology letters.

[23]  M. Parker,et al.  During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems , 2008, Cellular microbiology.

[24]  M. Toledano,et al.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis , 2007, Nature Reviews Molecular Cell Biology.

[25]  A. Driessen,et al.  Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria , 2007, Microbiology and Molecular Biology Reviews.

[26]  H. Wexler,et al.  Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. , 2007, Microbial pathogenesis.

[27]  Dongwoo Shin,et al.  A Positive Feedback Loop Promotes Transcription Surge That Jump-Starts Salmonella Virulence Circuit , 2006, Science.

[28]  J. Mekalanos,et al.  Characterization of the Vibrio cholerae vexAB and vexCD efflux systems , 2006, Archives of Microbiology.

[29]  T. Latifi,et al.  Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium , 2006, Molecular microbiology.

[30]  Jun Lin,et al.  Bile Salts Modulate Expression of the CmeABC Multidrug Efflux Pump in Campylobacter jejuni , 2005, Journal of bacteriology.

[31]  W. Shafer,et al.  Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. , 2005, The Journal of antimicrobial chemotherapy.

[32]  S. Peña-Llopis,et al.  Constitutive soxR Mutations Contribute to Multiple-Antibiotic Resistance in Clinical Escherichia coli Isolates , 2005, Antimicrobial Agents and Chemotherapy.

[33]  J. Imlay,et al.  Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpx- mutants of Escherichia coli. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Hooper Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  Canghai Lu,et al.  Quantitative and kinetic study of oxidative stress regulons using green fluorescent protein. , 2005, Biotechnology and bioengineering.

[36]  J. Imlay,et al.  Are Respiratory Enzymes the Primary Sources of Intracellular Hydrogen Peroxide?* , 2004, Journal of Biological Chemistry.

[37]  F. Fang Antimicrobial reactive oxygen and nitrogen species: concepts and controversies , 2004, Nature Reviews Microbiology.

[38]  H. Nikaido,et al.  Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein , 2003, Molecular microbiology.

[39]  M. Hogardt,et al.  Pretreatment of Mice with Streptomycin Provides a Salmonella enterica Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host , 2003, Infection and Immunity.

[40]  Arthur Thompson,et al.  Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica , 2002, Molecular microbiology.

[41]  P. Youderian,et al.  The Salmonella enterica sv. Typhimurium smvA, yddG and ompD (porin) genes are required for the efficient efflux of methyl viologen , 2002, Molecular microbiology.

[42]  J. Imlay,et al.  Alkyl Hydroperoxide Reductase Is the Primary Scavenger of Endogenous Hydrogen Peroxide in Escherichia coli , 2001, Journal of bacteriology.

[43]  J. Imlay,et al.  Hydrogen Peroxide Fluxes and Compartmentalization inside Growing Escherichia coli , 2001, Journal of bacteriology.

[44]  R. L. Santos,et al.  Animal models of Salmonella infections: enteritis versus typhoid fever. , 2001, Microbes and infection.

[45]  A. Yamaguchi,et al.  Novel Macrolide-Specific ABC-Type Efflux Transporter inEscherichia coli , 2001, Journal of bacteriology.

[46]  M H Saier,et al.  The drug/metabolite transporter superfamily. , 2001, European journal of biochemistry.

[47]  S. Levy,et al.  A soxRS-Constitutive Mutation Contributing to Antibiotic Resistance in a Clinical Isolate of Salmonella enterica (Serovar Typhimurium) , 2001, Antimicrobial Agents and Chemotherapy.

[48]  Corinaldesi,et al.  Role of antibiotic therapy on long‐term germ excretion in faeces and digestive symptoms after Salmonella infection , 2000, Alimentary pharmacology & therapeutics.

[49]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  F. Fang,et al.  Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. , 2000, Science.

[51]  M H Saier,et al.  The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. , 1999, Journal of molecular microbiology and biotechnology.

[52]  P. Garner,et al.  Antibiotics for treating salmonella gut infections. , 1999, The Cochrane database of systematic reviews.

[53]  N. Ganguly,et al.  Role of reactive oxygen species in Salmonella typhimurium-induced enterocyte damage. , 1998, Scandinavian journal of gastroenterology.

[54]  I. Paulsen,et al.  Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.

[55]  B. Finlay,et al.  Murine Salmonellosis Studied by Confocal Microscopy: Salmonella typhimurium Resides Intracellularly Inside Macrophages and Exerts a Cytotoxic Effect on Phagocytes In Vivo , 1997, The Journal of experimental medicine.

[56]  R. L. Lucas,et al.  Co‐ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression , 1996, Molecular microbiology.

[57]  T. Hill,et al.  Insertion of inverted Ter sites into the terminus region of the Escherichia coli chromosome delays completion of DNA replication and disrupts the cell cycle , 1995, Molecular microbiology.

[58]  D. Hinshaw,et al.  Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense. , 1995, Free radical biology & medicine.

[59]  H. Bremer,et al.  Control of the Escherichia coli rrnB P1 promoter strength by ppGpp , 1995, The Journal of Biological Chemistry.

[60]  J. Hearst,et al.  Genes acrA and acrB encode a stress‐induced efflux system of Escherichia coli , 1995, Molecular microbiology.

[61]  H. Voet,et al.  Increased neutrophil chemiluminescence production in patients with cystic fibrosis. , 1994, Metabolism: clinical and experimental.

[62]  H. Nikaido,et al.  Prevention of drug access to bacterial targets: permeability barriers and active efflux. , 1994, Science.

[63]  E. Cobo,et al.  Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. , 1993, The Journal of infectious diseases.

[64]  P. Heisig High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. , 1993, The Journal of antimicrobial chemotherapy.

[65]  F. Heffron,et al.  Recombination‐deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages , 1993, Molecular microbiology.

[66]  P. Rather,et al.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. , 1993, Microbiological reviews.

[67]  S. Levy,et al.  Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.

[68]  S. Opal,et al.  Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. , 1991, Annals of internal medicine.

[69]  J. Galán,et al.  Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling , 1990, Infection and immunity.

[70]  B. Bloom,et al.  Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene. , 1990, The Journal of clinical investigation.

[71]  S. Miller,et al.  A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Galán,et al.  Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. , 1989, Microbial pathogenesis.

[73]  F. Heffron,et al.  Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages , 1989, Infection and immunity.

[74]  C. Nathan Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. , 1987, The Journal of clinical investigation.

[75]  C. Haidaris,et al.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[76]  D. Hooper,et al.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans , 1985, Antimicrobial Agents and Chemotherapy.

[77]  I. Fridovich,et al.  Effects of molecular oxygen on detection of superoxide radical with nitroblue tetrazolium and on activity stains for catalase. , 1984, Analytical biochemistry.

[78]  Y. Chabbert,et al.  Role of porin proteins OmpF and OmpC in the permeation of beta-lactams , 1982, Antimicrobial Agents and Chemotherapy.

[79]  W. Soeller,et al.  Macrophage variants in oxygen metabolism , 1980, The Journal of experimental medicine.

[80]  J. Nelson,et al.  Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. , 1980, Pediatrics.

[81]  J. Carlsson,et al.  The recA+ gene product is more important than catalase and superoxide dismutase in protecting Escherichia coli against hydrogen peroxide toxicity , 1980, Journal of bacteriology.

[82]  H. Hsu,et al.  The comparative histopathology of primary and secondary lesions in murine salmonellosis. , 1980, British journal of experimental pathology.

[83]  V. McGovern,et al.  Pathology of salmonella colitis , 1979, The American journal of surgical pathology.

[84]  Mcgovern Vj,et al.  Pathology of salmonella colitis. , 1979 .

[85]  D. W. Day,et al.  The rectal biopsy appearances in Salmonella colitis , 1978, Histopathology.

[86]  J. Bennett,et al.  Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. , 1969, The New England journal of medicine.